NCT07067814

Brief Summary

The aim of the study is to evaluate the value of injection of methylene blue dye into the inferior thyroid artery for the help of the identification and dissection of recurrent laryngeal nerve, so thyroidectomy could be done with fewer complications in comparison to conventional technique

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 6, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 16, 2025

Completed
Last Updated

July 16, 2025

Status Verified

May 1, 2025

Enrollment Period

1.7 years

First QC Date

July 6, 2025

Last Update Submit

July 15, 2025

Conditions

Keywords

Recurrent laryngeal nerve identification

Outcome Measures

Primary Outcomes (1)

  • Easy and fast identification of recurrent laryngeal nerve

    Thyroid gland absorbed the dye and got stained blue while the RLN didn't take the dye and appeared as a white structure in the tracheoesophageal groove

    Procedure (Time taken for identification of the recurrent laryngeal nerve after delivery of thyroid lobe (in minutes))

Secondary Outcomes (1)

  • Lower intra-operative blood loss

    The duration of the procedure ranging from one to two hours

Study Arms (2)

Methylene blue group

ACTIVE COMPARATOR

After ligation of the superior pole, 0.5-1 ml of sterile methylene blue dye was injected into the inferior thyroid artery. The thyroid tissue absorbed the dye, while the RLN remained unstained, appearing as a white structure in the tracheoesophageal groove. This aided in its early and safe identification, reducing the risk of injury during dissection.

Drug: Methylene blue groupProcedure: Methylene blue group

Conventional technique group

NO INTERVENTION

the RLN was identified based on conventional anatomical landmarks without the use of dye. The nerve was traced along its expected course near the inferior thyroid artery and ligament of Berry

Interventions

After ligation of the superior pole, 0.5-1 ml of sterile methylene blue dye was injected into the inferior thyroid artery. The thyroid tissue absorbed the dye, while the RLN remained unstained, appearing as a white structure in the tracheoesophageal groove. This aided in its early and safe identification, reducing the risk of injury during dissection.

Methylene blue group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • All patients who present with simple nodular goiter, solitary thyroid nodule, controlled toxic goiter and failed medical treatment with indication for thyroidectomy.
  • Patents undergoing primary surgery (not recurrent).
  • Patients who are willing to undergo surgery under general anesthesia without any preoperative complications or major diseases.
  • Either gender in the age group of 18-60 years

You may not qualify if:

  • Previous thyroid surgery.
  • Malignant goiter.
  • Major cardiac diseases, renal diseases or patients who are unfit for surgery.
  • Methylene blue allergies.
  • Pregnancy.
  • Patients who refuse to participate in the study.
  • Presence of any preoperative cord pathology or patients with dysphonia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, Abbassia, Egypt

Location

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 1. : - Methylene blue group: After ligation of the superior thyroid pole, 0.5-1 ml of sterile methylene blue dye was injected into the inferior thyroid artery. The thyroid tissue absorbed the dye, while the RLN remained unstained, appearing as a white structure in the tracheoesophageal groove. This aided in its early and safe identification, reducing the risk of injury during dissection. 2. : Conventional technique group: the RLN was identified based on conventional anatomical landmarks without the use of dye. The nerve was traced along its expected course near the inferior thyroid artery and ligament of Berry
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2025

First Posted

July 16, 2025

Study Start

June 1, 2023

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

July 16, 2025

Record last verified: 2025-05

Locations